Market overview: The three major indices showed mixed results, with the Hang Seng Index rising by 0.77%. Dining and retail stocks were active, with Little Vegetable Garden surging over 11% and Mao Ge Ping rising over 9%.

The Network Technology stocks had mixed performances, with XIAOMI-W rising 3.62% and NTES-S dropping 2.73%; Property Services and Management stocks strengthened, with CG SERVICES increasing by 7.53% and GREENTOWN SER rising by 5.83%; the Dining stocks saw gains, with Little Garden increasing by 11.29% and XIABUXIABU rising by 8.89%.

Futu NewsMar 17 16:29

BioAsia Tech-B (02315.HK) plans to hold a Board of Directors meeting on March 26 to approve the annual performance.

Glory Capital announced on March 14 that the Board of Directors meeting for Baio Saitu-B (02315.HK) will be held on March 26, 2025 (Wednesday) to (including) (i) consider and approve the annual performance of the company and its subsidiaries for the year ending December 31, 2024, and its publication, and (ii) consider the payment of the final dividend (if any).

Gelonghui FinanceMar 14 16:49

BIOCYTOGEN-B: DATE OF BOARD MEETING

HKEXMar 14 16:33 · Announcements

All the way up! The Innovative Drugs Sector in Hong Kong stocks surged collectively, with multiple stocks doubling this year. Who is reshaping the valuation?

The rise in the Hong Kong stock market's Innovative Drugs Sector continues. Market analysts point out that this wave of Innovative Drugs momentum benefits from a combination of factors including market sentiment, policy, and the realization of the companies' own commercial value.

Securities TimesMar 13 09:50

Market Update | CloudTop New Shine's stock rises over 16%, breakthroughs in AI pharmaceutical development, and the valuation logic of Innovative Drugs in the Hong Kong stock market is changing.

① How can current AI technology break through the "double ten law" of a 10-year research and development cycle and a cost of 1 billion dollars in traditional drug development? ② The P/S of innovative drugs in the Hong Kong stock market is at a historical low, how will AI-enabled pharmaceutical companies reconstruct the valuation logic?

cls.cnMar 7 13:02

Hong Kong stocks fluctuation | Bai'ao Saituo-B (02315) rises over 10% against the market trend, having completed the localization deployment of the AI-driven antibody drug development platform DeepSeek.

Biotech Company B (02315) rises by more than 10% against the market, as of the time of writing, up 10.07%, priced at 12.02 HKD, with a transaction amount of 0.1252 million HKD.

Zhitong FinanceMar 7 09:52